Sazbo B, Schultheiss A
Pharmakologisches Institut der Universität, Freiburg i. Br., Federal Republic of Germany.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Oct;342(4):469-76. doi: 10.1007/BF00169466.
The aim of the study was to determine the sites of action of intravenously administered desipramine on the sympathetic nervous system in anaesthetized rabbits (alfadolone + alfaxalone). Renal postganglionic sympathetic nerve activity was measured in order to determine central nervous and ganglionic effects. The clearance of noradrenaline from the plasma was determined with an isotope tracer method. From the noradrenaline clearance and the plasma concentration of noradrenaline the noradrenaline spillover rate was calculated. These parameters as well as blood pressure and heart rate were measured before (basal values) and at the end of 20-min infusions of sodium nitroprusside, which was given in order to modulate efferent sympathetic nerve activity through the baroreceptors. Desipramine 0.5 mg kg-1 + 0.05 mg kg-1 h-1 (bolus injection followed by infusion) and 2 mg kg-1 + 0.2 mg kg-1 h-1 dose-dependently inhibited basal sympathetic nerve activity and the noradrenaline clearance. Desipramine had no effect on basal blood pressure, noradrenaline spillover rate or heart rate. Nitroprusside produced hypotension and simultaneously increased sympathetic nerve activity, noradrenaline spillover rate and heart rate; the clearance of noradrenaline was reduced with decreasing blood pressure. The relationship between sympathetic nerve activity and blood pressure was shifted by desipramine in a manner indicating central sympathoinhibition. Desipramine had no effect on the relationship of the noradrenaline spillover rate to blood pressure, whereas it shifted the heart rate-blood pressure relationship in a manner indicating an enhancement of reflex cardioacceleration. In a separate series of experiments, desipramine also inhibited sympathetic nerve activity in baroreceptor-denervated animals. The results show that desipramine centrally inhibits sympathetic outflow in the rabbit.(ABSTRACT TRUNCATED AT 250 WORDS)
本研究的目的是确定静脉注射地昔帕明对麻醉兔(阿法多龙+阿法沙龙)交感神经系统的作用部位。测量肾节后交感神经活动以确定中枢神经和神经节效应。用同位素示踪法测定血浆中去甲肾上腺素的清除率。根据去甲肾上腺素清除率和血浆去甲肾上腺素浓度计算去甲肾上腺素溢出率。在静脉输注硝普钠20分钟之前(基础值)和结束时测量这些参数以及血压和心率,输注硝普钠是为了通过压力感受器调节传出交感神经活动。0.5mg/kg + 0.05mg/(kg·h)(推注后持续输注)和2mg/kg + 0.2mg/(kg·h)的地昔帕明剂量依赖性地抑制基础交感神经活动和去甲肾上腺素清除率。地昔帕明对基础血压、去甲肾上腺素溢出率或心率无影响。硝普钠导致低血压,同时增加交感神经活动、去甲肾上腺素溢出率和心率;随着血压降低,去甲肾上腺素清除率降低。地昔帕明使交感神经活动与血压之间的关系发生改变,表明存在中枢性交感神经抑制。地昔帕明对去甲肾上腺素溢出率与血压之间的关系无影响,而它改变了心率-血压关系,表明反射性心动加速增强。在另一系列实验中,地昔帕明也抑制了压力感受器去神经动物的交感神经活动。结果表明,地昔帕明在中枢抑制兔的交感神经传出。(摘要截短于250字)